??? ? ???? ?????, 2021? 9? 9? /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd.(?? Gan & Lee, ?? ??: 603087.SH)? ?57? ?? ???????(European Association for the Study of Diabetes, EASD) ???? ?? ?? ?? ??? ?? ?? ?? ??? ?? ???? ??? ????. ? ??? ?? 27??? 10? 1??? ?? ??? ??? ????.

2021? 9? 30? 11:45~13:15(CEST)?? ??? ?? ??? ???? ??? ????.

- ??? GLP-1 ???, GZR18: ?2? ??? ???? ?? ? ??(Novel GLP-1 analogue, GZR18: a preclinical evaluation in type 2 diabetes models)

- ??? ??? ???? ?????? ??? ???? ??? ??????? ?? ??? aspart? ??? ???? ???? 3? ?? ??(Phase 3 confirmatory study comparing efficacy and safety of proposed biosimilar and reference insulin aspart, combined with metformin, in patients with diabetes)

??? ???, 2021? 9? 30? 11:45~13:15(CEST)?? ??? 1? ?????? ?? ?? ??? ??? ????.

- ??? ?????? ??? aspart(GL-ASP)? ???? ??? ??, EU?? ??? ?? ??? aspart? ?????? ??? ?? ???(pharmacokinetic, PK)? ???(pharmacodynamic, PD)? ???(Proposed biosimilar insulin aspart (GL-ASP) shows pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence to US-licenced and EU-authorised insulin aspart)

- ??? ?????? ??? lispro (GL-LIS)? ???? ??? ??, EU?? ??? ?? ??? lispro? ?????? ??? ?? ???(pharmacokinetic, PK)? ???(pharmacodynamic, PD)? ???(Proposed biosimilar insulin lispro (GL-LIS) shows pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence to US-licenced and EU-authorised insulin lispro)

- ??? ?????? ??? glargine(GL-GLA)? ???? ??? ??, EU?? ??? ?? ??? glargine? ?????? ??? ?? ???(pharmacokinetic, PK)? ???(pharmacodynamic, PD)? ???(Proposed biosimilar insulin glargine (GL-GLA) shows pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence to US-licenced and EU-authorised insulin glargine)

?? EASD ???? ??? ??? ?? ???? Gan & Lee? ?? ?? ?????? ??? ????. ??? ???, ?? ??? ??? ??? ??? ?? ???? ???? ?? Gan & Lee? ??? ???? ???. Global Medical Affairs ??? Michelle Mazuranic? "??? ??? ??? ?? ???? ???? ?? ?? ??"?? "EASD? ?? ?? ?? ?? ??? ? ?? ??? ????"?? ???. GZR18, GL-ASP (?? 3?), GL-ASP (1?), GL-LIS ? GL-GLA? ?? ??? ?? 463?, 513?, 510?, 514? ? 511???.

Gan & Lee ??

Gan & Lee Pharmaceuticals? ?? ??? ?? ??? ?? ???? ????. ???? ?? ???? glargine ??(Basalin(R)), ??? ???? lispro ??(Prandilin?), ??? ???? aspart ??(Rapilin?), ?? protamine zinc lispro ??(25R)(Prandilin(R)25), aspart 30 ??(Rapilin?30), ? ???? ??? ?? ??? ??? ?? protamine ?? ??? ?? (30R) (Similin(R)30) ?? ??? ???? ?? ?? ???? ??? ????? ?????. Gan & Lee? ???? ??? ??? ???(GanleePen?), ??? ? ??(GanleeFine(R)) ? ???? ??? ? ?? ????? ???? ??.

?? Gan & Lee? ?? ??? ?? ??? ???? ?? ??? ????. Gan & Lee? ??? ??? ????? ??? ?? ??? ?? ???? ???, ??? ??? ??? ??, ?? ??, ? ?? ???? ??? ?? ?? ?? ? ??? ????? ???? ??. ?? ??? ???? investorrelations@ganlee.us? ????.

??:

1. Leona Plum- Morschel, et. al. Proposed biosimilar insulin aspart (GL-ASP) shows pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence to US-licenced and EU-authorised insulin aspart. Diabetes. June 22, 2021.

2. Eric Zijlstra, et. al. Proposed biosimilar insulin lispro (GL-LIS) shows pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence to US-licenced and EU-authorised insulin lispro. Diabetes. June 22, 2021.

3. Tim Heise, et. al. Proposed biosimilar insulin glargine (GL-GLA) shows pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence to US-licenced and EU-authorised insulin glargine. Diabetes. June 22, 2021.

Gina Antonucci, #: 888-288-5395, investorrelations@ganlee.us